Dr Angeles Escarti-Nebot is a Principal Consultant at Scendea with experience in the initiation, management, and execution of regulatory projects from early development to marketing authorization. Angeles has previously held positions in Paraxel and PhamaLex and her areas of expertise include regulatory strategy, non-clinical and quality development programs for the EU and US markets. Angeles has a strong scientific background with more than seven years’ experience in biotechnology research and more than 10 years’ experience in a regulatory environment. Angeles holds a PhD in molecular biology (gene and cell-based therapies), BA in Pharmacy, MS in Clinical Genetics and MS in Neuropharmacology.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.